Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...

At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...

The Federal Trade Commission has released its second report digging into how the business practices of pharmacy benefit managers could be inflating drug costs in the U.S., in the latest and likely ...

WASHINGTON, Jan 14 (Reuters) - The nation's three largest pharmacy ... FTC spokesperson told reporters in a press briefing, adding that the figure was "probably an underestimate." Pharmacy benefit ...